Quick Search

 

 


 

 

Result Summary for 101468/099

Result Summary
Protocol ID: 101468/099
Clinical Study ID: SK&F 101468-099
Official Title: An Open Study to Assess the Safety and Efficacy of Ropinirole at a Flexible Oral Dose of 0.25-8.0mg Three Times a Day for One Year in Parkinsonian Patients Not Optimally Controlled on L-Dopa
Phase: Phase 3
Study Indications or Diseases:
  • Parkinson Disease
Generic Name: ropinirole
Trade/Product Name: requip;requip
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.